News | Heart Valve Technology | August 26, 2016

PinnacleHealth Achieves First U.S. Edwards Intuity Aortic Valve Implants

Pennsylvania health system deployed valve in first two U.S. patients via minimally invasive intercostal surgical aortic valve replacement

Edwards Intuity aortic valve, surgical aortic valve replacement, PinnacleHealth, first U.S. implants

August 26, 2016 — This week, PinnacleHealth, Harrisburg, Pa., became the first hospital in the country to implant the Edwards Intuity Elite valve, a rapid deployment device for surgical aortic valve replacement, after U.S. Food and Drug Administration (FDA) approval.

The team — led by Mubashir Mumtaz, M.D., FACS, FACC, chief of cardiothoracic surgery and surgical director of the structural heart program at PinnacleHealth — replaced the aortic valve in two patients using a technique called intercostal surgical aortic valve replacement (iSAVR). This minimally invasive approach accesses the heart through the rib space without dividing any major muscle groups, rib or cartilage. The Edwards Intuity Elite valve system facilitates this approach, which was developed at PinnacleHealth.

“We are able to offer our patients with aortic stenosis less invasive surgical options such as iSAVR. This can mean less trauma, quicker recovery and decreased need for blood transfusions,” stated Mumtaz.

The valve system is designed to facilitate and streamline complex aortic valve replacements, thereby offering a cutting-edge treatment option for patients with aortic valve disease.

PinnacleHealth was among the top enrollers in the United States in the TRANSFORM clinical trial, which evaluated the safety and efficacy of the Edwards Intuity valve system. The FDA recently approved the Intuity valve due to its positive clinical performance. Results showed that, at one year, the valve system was highly effective and may reduce cross-clamp time and cardiopulmonary bypass time, compared to times recorded in the Society of Thoracic Surgeons' (STS) Adult Cardiac Database. This may provide patient benefits such as decreased mortality and morbidity, less time in an intensive care unit and reduced total hospital stay.

“Participation in clinical trials can lead to improved care and innovations, particularly for our complex cardiac patients,” stated Mumtaz. “This milestone in cardiac treatment can reassure the community that nationally recognized heart care is available close to home.”

According to an article published in the Journal of the American College of Cardiology, aortic stenosis (AS) is the most common valvular heart disease in developed countries with prevalence estimated between 3 and 23 percent. Aortic stenosis mainly affects older people, due to scarring and calcium buildup in the valve cusp. With a growing elderly population, aortic stenosis is anticipated to become a major public health concern.

For more information: www.edwards.com

Related Content

Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery| September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery| May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery| May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery| May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery| May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery| May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Edwards Intuity Elite sutureless aortic valve, first implants in Connecticut, WCHN, Western Connecticut Health Network
News | Cardiovascular Surgery| February 16, 2017
Western Connecticut Health Network (WCHN) cardiothoracic surgeons Cary Passik, M.D., and Robert Gallagher, M.D., were...
open-heart surgery, PCI, percutaneous coronary intervention, NOBLE trial, left main coronary artery disease, LMCAD, TCT 2016
News | Cardiovascular Surgery| November 03, 2016
Coronary artery bypass (CABG) surgery is the standard treatment for revascularization in patients with left main...
Overlay Init